| Thalidomide | Approved Investigational Withdrawn | FOSB | 2354 |
upregulated | Thalidomide analog results in increased expression of FOSB mRNA | 19q13.32 | |
| Thalidomide | Approved Investigational Withdrawn | FZD8 | 8325 |
downregulated | Thalidomide results in decreased expression of FZD8 mRNA | 10p11.21 | |
| Thalidomide | Approved Investigational Withdrawn | HERPUD1 | 9709 |
upregulated | Thalidomide analog results in increased expression of HERPUD1 mRNA | 16q13 | |
| Thalidomide | Approved Investigational Withdrawn | HSPH1 | 10808 |
upregulated | Thalidomide analog results in increased expression of HSPH1 mRNA | 13q12.3 | |
| Thalidomide | Approved Investigational Withdrawn | IL1R1 | 3554 |
downregulated | Thalidomide results in decreased expression of IL1R1 mRNA | 2q11.2-q12.1 | |
| Thalidomide | Approved Investigational Withdrawn | IL6ST | 3572 |
downregulated | Thalidomide results in decreased expression of IL6ST mRNA | 5q11.2 | |
| Thalidomide | Approved Investigational Withdrawn | ING3 | 54556 |
upregulated | Thalidomide analog results in increased expression of ING3 mRNA | 7q31.31 | |
| Thalidomide | Approved Investigational Withdrawn | JUN | 3725 |
upregulated | Thalidomide analog results in increased expression of JUN mRNA | 1p32.1 | |
| Thalidomide | Approved Investigational Withdrawn | LATS2 | 26524 |
upregulated | Thalidomide analog results in increased expression of LATS2 mRNA | 13q12.11 | |
| Thalidomide | Approved Investigational Withdrawn | NR4A1 | 3164 |
upregulated | Thalidomide analog results in increased expression of NR4A1 mRNA | 12q13.13 | |
| Thalidomide | Approved Investigational Withdrawn | NR4A2 | 4929 |
upregulated | Thalidomide analog results in increased expression of NR4A2 mRNA | 2q22-q23 | |
| Thalidomide | Approved Investigational Withdrawn | PPP1R15A | 23645 |
upregulated | Thalidomide analog results in increased expression of PPP1R15A mRNA | 19q13.2 | |
| Thalidomide | Approved Investigational Withdrawn | RELB | 5971 |
upregulated | Thalidomide analog results in increased expression of RELB mRNA | 19q13.32 | |
| Thalidomide | Approved Investigational Withdrawn | SNX16 | 64089 |
upregulated | Thalidomide analog results in increased expression of SNX16 mRNA | 8q21.13 | |
| Thalidomide | Approved Investigational Withdrawn | TEK | 7010 |
downregulated | Thalidomide results in decreased expression of TEK mRNA | 9p21.2 | |
| Thalidomide | Approved Investigational Withdrawn | TGFBR1 | 7046 |
downregulated | Thalidomide results in decreased expression of TGFBR1 mRNA | 9q22.33 | |
| Thalidomide | Approved Investigational Withdrawn | TNF | 7124 |
downregulated | Thalidomide results in decreased expression of TNF mRNA | 6p21.33 | |
| Thalidomide | Approved Investigational Withdrawn | TNFRSF1A | 7132 |
downregulated | Thalidomide results in decreased expression of TNFRSF1A mRNA | 12p13.31 | |
| Thalidomide | Approved Investigational Withdrawn | TNFRSF1B | 7133 |
downregulated | Thalidomide results in decreased expression of TNFRSF1B mRNA | 1p36.22 | |
| Thalidomide | Approved Investigational Withdrawn | TP53 | 7157 |
upregulated | Thalidomide analog results in increased expression of TP53 mRNA | 17p13.1 | |
| Thalidomide | Approved Investigational Withdrawn | TRIB3 | 57761 |
upregulated | Thalidomide analog results in increased expression of TRIB3 mRNA | 20p13 | |
| Thalidomide | Approved Investigational Withdrawn | VEGFA | 7422 |
downregulated | Thalidomide results in decreased expression of VEGFA mRNA | 6p21.1 | |
| Thalidomide | Approved Investigational Withdrawn | WNT5B | 81029 |
downregulated | Thalidomide results in decreased expression of WNT5B mRNA | 12p13.33 | |
| Theophylline | Approved Investigational | ABL2 | 27 |
downregulated | Theophylline results in decreased expression of ABL2 mRNA | 1q25.2 | |
| Theophylline | Approved Investigational | ACTR2 | 10097 |
downregulated | Theophylline results in decreased expression of ACTR2 mRNA | 2p14 | |